Showing 1861-1870 of 8649 results for "".
- New “Eying the Future" School Program Seeks to Fuel Student Interest in Optometryhttps://modernod.com/news/new-eying-the-future-school-program-seeks-to-fuel-student-interest-in-optometry/2482568/Latinos en Optometry has partnered with Transitions Optical to launch "Eying the Future," a free in-school educational program specifically designed to inspire middle and high school students in Latino communities to consider
- EMA’s CHMP Issues Negative Opinion of Syfovre for GA; Apellis to Seek Re-Examinationhttps://modernod.com/news/emas-chmp-issues-negative-opinion-for-syfovre-for-ga-apellis-to-seek-re-examination/2482336/The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the marketing authorization application (MAA) of Apellis’s intravitreal pegcetacoplan for the treatment of geographic atrophy (GA). “Although th
- Apellis Receives Negative Opinion for Pegcetacoplan for GA in the EU; Plans to Seek Re-Examination of Applicationhttps://modernod.com/news/apellis-receives-negative-opinion-for-pegcetacoplan-for-ga-in-the-eu-plans-to-seek-re-examination-of-application/2482083/Apellis Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a negative opinion on the marketing authorization application (MAA) of intravitreal pegcetacoplan for the treatment of geographic atrophy (GA) secondary to
- Pfizer, BioNTech Seek EU Nod to Allow COVID-19 Vaccine Use in Younger Teenshttps://modernod.com/news/pfizer-biontech-seek-eu-nod-to-allow-covid-19-vaccine-use-in-younger-teens/2479158/Pfizer and BioNTech said they have asked the European Medicines Agency (EMA) to extend the conditional marketing authorization for their COVID-19 vaccine Comirnaty to adolescents 12 to 15 years of age. The companies recently made a similar request to the FDA for the vaccine, which is already auth
- Ophthalmic World Leaders Announces Development and Networking Program for Executives Seeking Corporate Board Positionshttps://modernod.com/news/ophthalmic-world-leaders-announces-development-and-networking-program-for-executives-seeking-corporate-board-positions/2479130/Ophthalmic World Leaders (OWL) has announced its inaugural “Get-On-Board with OWL” program. Primarily aimed at executive-level women and underrepresented communities, this new offering will help attendees develop the skills and connections required to secure board positions in a rapid
- Pfizer, BioNTech Seek Expanded Emergency Use of COVID-19 Vaccine in Younger Adolescentshttps://modernod.com/news/pfizer-biontech-seek-expanded-emergency-use-of-covid-19-vaccine-in-younger-adolescents/2479068/Pfizer and BioNTech said they have asked the FDA to amend the emergency-use authorization (EUA) for their coronavirus vaccine BNT162b2 to include use in adolescents 12-to-15 years of age, adding they will be making similar requests to other global regulatory bodies in the coming days. The mRNA-ba
- Bayer, Novartis Lose Case Seeking to End NHS Use of Avastin in Wet AMDhttps://modernod.com/news/bayer-novartis-lose-case-seeking-to-end-nhs-use-of-avastin-in-wet-amd/2479853/The UK High Court on Friday ruled that 12 NHS bodies in the north-east of England can continue to use Roche’s Avastin (bevacizumab) for the treatment of wet age-related macular degeneration (AMD) after dismissing a challenge by Bayer and Novartis. In the case, Bayer and Novartis, which mark
- University of Minnesota Seeks to Enroll Health Care Workers for COVID-19 Clinical Trialhttps://modernod.com/news/university-of-minnesota-seeks-to-enroll-health-care-workers-for-covid-19-clinical-trial/2477477/The University of Minnesota is launching a clinical trial on a post-exposure treatment for coronavirus COVID-19 disease. This trial is testing hydroxychloroquine, an FDA-approved medicine for the prevention and treatment of malaria, available since the 1950s and known
- Staar Surgical Announces Agreement in US with IQ Laser Visionhttps://modernod.com/news/staar-surgical-announces-agreement-in-us-with-iq-laser-vision/2482269/Staar Surgical announced a strategic agreement with IQ Laser Vision, which has locations across California and Texas. IQ Laser Vision will make EVO ICL lenses a primary option for patients seeking surgical vision correction within the range of -3D to -20D. IQ Laser V
- Presbia Abandons Flexivue Microlens, Lays Off All But 3https://modernod.com/news/presbia-abandons-flexivue-microlens-lays-off-all-but-3/2476501/Presbia said it spiked its Flexivue microlens development program in the face of FDA headwinds, laying off all but three of its employees as it seeks investors to bail it out, according to a Mass Device report. Earlier this month, the Irvine, Calif.-based company